IDH1 and Ollier disease: Zhang and Alman reviewed genetic findings in enchondromatosis and found somatic mutations in IDH1/2 to be the most common abnormality and suggest that pharmacologic therapies could target this gene or downstream pathways affected by the mutation [1].